FDA Inspection 1196058 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on Jan 26, 2023 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 26, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Miami, FL (United States)